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One of the major challenges is the increased use of “marginal” grafts for liver 
transplantation. This fact has obliged physicians to use liver grafts with moderate 
steatosis, although they show higher vulnerability against cold ischemia-
reperfusion injury than normal livers. Steatosis results from an abnormal 
accumulation of fat in hepatic sinusoids, leading to a severe obstruction of hepatic 
flow with important alterations in liver microcirculation. 
The composition of the preservation solution is a crucial factor in the preservation 
of a liver graft, especially when the liver is steatotic. Although the University of 
Wisconsin (UW) is useful for liver graft preservation, its limitations are well known; 
UW contains high K_ (125 mmol/L) and low Na_ (30 mmol/L) concentrations, 
which provoke vasoconstriction. In addition, the presence of the colloid, 
hydroxylethyl statch (HES), can trigger red blood cell aggregation, thereby 
promoting stasis in hepatic sinusoids and limiting the efficiency of graft washout, 
thereby exacerbating microcirculatory disturbances in steatotic livers and 
compromising graft outcomes after transplantation. 
Recently, we have described Institute Georges Lopez preservation solution (IGL-1) 
as an effective alternative to UW. IGL-1 composition is characterized by the 
reversion of the ionic K/Na concentrations and the substitution of HES by 
polyethylene glycol 35 (PEG-35). These characteristics of IGL-1 render it suitable 
for abdominal organ preservation including fatty liver grafts. The mechanisms 
induced by the use of IGL-1 solution to prevent liver cold iscemia-reperfusion injury 
include influences on cell signaling in fatty livers.  
 
IGL-1 solution effectively protects normal and moderately steatotic livers against 
cold ischemia-resperfusion injury. These beneficial effects have initially been 
associated with the involvement of freely diffusible molecules, such as nitric oxide 
(NO), which act in an autocrine and/or paracrine manner to effectively trigger and 
differentially activate cytoprotective cell signaling pathways during cold 
ischemiareperfusion, namely, hypoxia-induced factor-1 (HIF-1) and heme 
oxygenase-1 (HO-1), respectively. 
 
 
The benefits of IGL-1 are mediated by NO. Constitutive nitric oxide synthase is 
activated, leading to the generation of NO, which efficiently protects fatty livers 
against cold ischemia-reperfusion. This change was evidenced by prevention of 
steatotic and nonsteatotic liver injuries (diminished aspartate transferase/alanine 
transferase), as well as an enhanced hepatic function as evidenced by increased 
bile production and diminished vascular resistance. The advantages of IGL-1 were 
exacerbated when an anti-ischemia drug such as trimetazidine (antioxidant and 
NO donor) was used as an additive.  
NO is a diffusible, vasodilator molecule generated by liver endothelia. It has a 
pivotal, dual role: it prevents exacerbated oxidative stress from occurring in fatty 
livers subjected to ischemia-reperfusion injury and liver transplantation, and it 
ameliorates the deficient microcirculation existing in steatotic livers, as a 
consequence of fat accumulation in hepatic sinusoids, contributing thus to improve 
the hepatic tissue oxygenation. Additional benefits of NO generation in preserved 
livers may be associated with its inhibitory action on endothelins, and its potent 
effects to counter liver vasoconstrictor peptides formed during liver graft 
reperfusion.  
In addition, most current data have focused on whether NO regulates 
cytoprotective signal transduction pathways during cold storage and normothermic 
reperfusion, as HIF-1 and HO-1, which seem to ameliorate fatty liver preservation.  
 
Lack of an oxygen supply to the graft induces activation of HIF-1, as an “adaptative 
response” to oxygenation changes occurring during cold preservation. Active HIF-1 
is a heterodimer consisting of an inducible HIF-1 alpha subunit and another 
constitutively expressed molecule called HIF-1 beta. During ischemia/hypoxia, HIF-
1 alpha accumulates but is extremely labile in normoxic conditions.Its stability is 
drastically reduced by the oxygen-dependent enzymatic hydroxylation of proline 
residues by prolyl hydroxylase enzymes. It has been shown that NO impairs 
normoxic degradation of HIF-1 alpha by inhibition of HIF-1 prolyl-hydroxylases.This 
fact contributes to stabilization and subsequent accumulation as previously 
reported by several authors.  
Significant activation of HIF-1 alpha originates in fatty livers preserved in IGL-1 
solution. In addition, HIF-1 alpha is maintained after normoxic reperfusion as a 
consequence of NO generation occurring in IGL-1 cold preservation. It has been 
reported by several authors that NO stabilizes HIF-1 alpha in normoxia by directly 
inhibiting prolyl-hydroxylase enzymes. 
Importantly, HIF-1 signaling has been implicated in the development of hypoxia-
induced delayed protection. In this line, recent studies have shown that 
cytoprotective effects of HIF-1 are closely related to HO-1.It is clear that HO-1 up-
regulation protects a fatty liver from a genetically fat Zucker rat liver against 
ischemia-reperfusion injury20, consequently, it improves extended preservation of 
liver grafts. HIF-1 accumulation among fatty livers preserved in IGL-1 occurred 
concomitant with overexpression of HO-1 after reperfusion favoring graft protection 
against cold ischemia-reperfusion injury. 
 
In summary, NO is generated during IGL-1 static preservation and is crucial for 
enhanced preservation of fatty liver grafts. It up-regulates important protective cell 
signaling as HIF-1 alpha and HO-1, which are important for improving liver graft 
recovery, especially when steatosis is present.  
 
 
